한빛사논문
Hong-Jai Park a, Min Sun Shin a, Junghee J. Shin a, Hyoungsu Kim a,b, Byunghyun Kang c, Jennefer Par-Young a, Serhan Unlu a, Yuliya Afinogenova a, Jason Catanzaro d, Juan Young e, Minhyung Kim f, Sang Jin Lee a,g, Sangchoon Jeon h, Sungyong You f, Michael K. Racke i, Richard Bucala a, Insoo Kang a
aDepartment of Internal Medicine (Section of Rheumatology, Allergy & Immunology), Yale University School of Medicine, New Haven, CT, 06520, USA
bDepartment of Internal Medicine, Hallym University School of Medicine, Chuncheon, Gangwon-do, 24252, South Korea
cMucosal Immunology Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, 20892, USA
dSection of Pulmonary, Allergy, Immunology and Sleep Medicine, Department of Pediatrics, Yale University School of Medicine, New Haven, CT, 06520, USA
eDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, 06511, USA
fDepartment of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA
gDepartment of Internal Medicine, Kyungpook National University School of Medicine, Daegu, 41944, South Korea
hYale University School of Nursing, West Haven, CT, 06516, USA
iQuest Diagnostics, 500 Plaza Dr, Secaucus, NJ, 07094, USA
Corresponding author : Insoo Kang
Abstract
Background: The innate immune cytokine interleukin (IL)-1 can affect T cell immunity, a critical factor in host defense. In a previous study, we identified a subset of human CD4+ T cells which express IL-1 receptor 1 (IL-1R1). However, the expression of such receptor by viral antigen-specific CD4+ T cells and its biological implication remain largely unexplored. This led us to investigate the implication of IL-1R1 in the development of viral antigen-specific CD4+ T cell responses in humans, including healthy individuals and patients with primary antibody deficiency (PAD), and animals.
Methods: We characterized CD4+ T cells specific for SARS-CoV-2 spike (S) protein, influenza virus, and cytomegalovirus utilizing multiplexed single cell RNA-seq, mass cytometry and flow cytometry followed by an animal study.
Findings: In healthy individuals, CD4+ T cells specific for viral antigens, including S protein, highly expressed IL-1R1. IL-1β promoted interferon (IFN)-γ expression by S protein-stimulated CD4+ T cells, supporting the functional implication of IL-1R1. Following the 2nd dose of COVID-19 mRNA vaccines, S protein-specific CD4+ T cells with high levels of IL-1R1 increased, likely reflecting repetitive antigenic stimulation. The expression levels of IL-1R1 by such cells correlated with the development of serum anti-S protein IgG antibody. A similar finding of increased expression of IL-1R1 by S protein-specific CD4+ T cells was also observed in patients with PAD following COVID-19 mRNA vaccination although the expression levels of IL-1R1 by such cells did not correlate with the levels of serum anti-S protein IgG antibody. In mice immunized with COVID-19 mRNA vaccine, neutralizing IL-1R1 decreased IFN-γ expression by S protein-specific CD4+ T cells and the development of anti-S protein IgG antibody.
Interpretation: Our results demonstrate the significance of IL-1R1 expression in CD4+ T cells for the development of viral antigen-specific CD4+ T cell responses, contributing to humoral immunity. This provides an insig
논문정보
관련 링크
연구자 키워드
연구자 ID
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기